901 related articles for article (PubMed ID: 1675573)
1. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part III: Smooth muscle, gastrointestinal and miscellaneous systems.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Kojima H
Arzneimittelforschung; 1991 Jan; 41(1):25-31. PubMed ID: 1675570
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular properties of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N- methylbenzamide.
Hirohashi M; Takasuna K; Asano M; Ryokawa Y; Tamura K
Arzneimittelforschung; 1993 May; 43(5):578-83. PubMed ID: 8329003
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-adrenoceptor-blocking properties of midaglizole (DG-5128) in rats.
Hirohashi M; Tanaka M; Suzuki I; Akashi A
Arch Int Pharmacodyn Ther; 1990; 306():75-86. PubMed ID: 1981668
[TBL] [Abstract][Full Text] [Related]
6. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.
Kopia GA; Kopaciewicz LJ; Ruffolo RR
J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028
[TBL] [Abstract][Full Text] [Related]
7. [General pharmacological actions of traxanox sodium. II. Effects on the cardiovascular system].
Nakamura T; Miura Y; Aihara K; Satoh H; Goto K; Tsumagari T
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):79-92. PubMed ID: 6137441
[TBL] [Abstract][Full Text] [Related]
8. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
Moreira TS; Takakura AC; Menani JV; Colombari E
Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
[TBL] [Abstract][Full Text] [Related]
9. [The effect of yohimbine and idazoxan on the systemic and regional hemodynamics of waking rats].
Ivashev MN; Medvedev OS; Giulumian AD
Farmakol Toksikol; 1991; 54(5):20-2. PubMed ID: 1686868
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of 1-(3,4-dimethoxyphenyl)-2-(4-diphenylmethylpiperazinyl) ethanol and possible mechanisms involved.
Kushiku K; Ohba M; Araki T; Mikagi T; Katsuragi T; Furukawa T
Arzneimittelforschung; 1989 Apr; 39(4):458-63. PubMed ID: 2751731
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
12. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
[TBL] [Abstract][Full Text] [Related]
13. Effects of brotizolam on cardiovascular functions and autonomic nervous system.
Kushiku K; Morishita H; Furukawa T; Kitagawa H; Ueno K; Kitagawa H; Kohei H
Arzneimittelforschung; 1986 Mar; 36(3A):552-9. PubMed ID: 3718577
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of buflomedil and possible mechanisms involved.
Kushiku K; Ohba M; Mikagi T; Nuki S; Araki Y; Furukawa T
Arzneimittelforschung; 1989 Jun; 39(6):670-7. PubMed ID: 2775333
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
Jolly SR; Smith RD; Wolf PS; Russ TP
Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
[TBL] [Abstract][Full Text] [Related]
17. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
Hahn RA; MacDonald BR
J Pharmacol Exp Ther; 1984 Sep; 230(3):558-68. PubMed ID: 6470973
[TBL] [Abstract][Full Text] [Related]
18. Effects of ibopamine on systemic, pulmonary and regional hemodynamics. Experimental investigations in anesthetized dogs.
Merlo L; Ghirardi P; Brusoni B; Mussini E; Marchetti G
Arzneimittelforschung; 1986 Feb; 36(2A):304-11. PubMed ID: 3707641
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic mechanisms underlying cardiac and vascular responses to cocaine in conscious rats.
Branch CA; Knuepfer MM
J Pharmacol Exp Ther; 1992 Nov; 263(2):742-51. PubMed ID: 1359113
[TBL] [Abstract][Full Text] [Related]
20. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
Hohage H; Schlatter E; Greven J
Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]